Table 4.
Mean distance to recommended levels of cardio-metabolic risk factors among women with MS.
| Clinical & biochemical risk factors | Women with MS (n=148) | p-value | |
|---|---|---|---|
| In PCOS (n=44); Mean (±SD) | In NO PCOS (n=104); Mean (±SD) | ||
| Waist circumference | 22.18 (3.77) | 16.46 (2.58) | 0.000** |
| HDL (mmol) | 0.65 (0.15) | 0.43 (0.12) | 0.000** |
| LDL (mmol) | 1.40 (0.19) | 0.70 (0.1) | 0.000** |
| TC (mmol) | 1.10 (0.14) | 0.74 (0.22) | 0.000** |
| TG (mmol) | 0.56 (0.11) | 0.45 (0.05) | 0.000* |
| FBS (mmol) | 1.45 (0.32) | 1.5 (0.22) | 0.762ns |
| Systolic BP (mmhg) | 13.42 (2.53) | 9.27 (2.58) | 0.000* |
| Diastolic BP (mmhg) | 7.62 (1.07) | 7.45 (1.67) | 0.534ns |
ns
No statistically significant difference between PCOS groups at the 0.05 level.
*
Statistical significant difference between PCOS groups at the 0.01level.